Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

The Impact of the Microbiome on Immunosenescence.

Amsterdam D, Ostrov BE.

Immunol Invest. 2018 Nov;47(8):801-811. doi: 10.1080/08820139.2018.1537570. Review.

PMID:
31282802
2.

Immunomodulatory interplay of the microbiome and therapy of rheumatic diseases.

Ostrov BE, Amsterdam D.

Immunol Invest. 2017 Nov;46(8):769-792. doi: 10.1080/08820139.2017.1373828. Review.

PMID:
29058546
3.

Immunotherapeutic Approaches for the Control and Eradication of HIV.

Amsterdam D.

Immunol Invest. 2015;44(8):719-30. doi: 10.3109/08820139.2015.1096680. Review.

PMID:
26575461
4.

The interference of monoclonal antibodies with laboratory diagnosis: clinical and diagnostic implications.

Ostrov BE, Amsterdam D.

Immunol Invest. 2013;42(8):673-90. doi: 10.3109/08820139.2013.837918. Review.

PMID:
24094033
5.

A randomized clinical trial comparing metabolic parameters after 48 weeks of standard- and low-dose stavudine therapy and tenofovir disoproxil fumarate therapy in HIV-infected South African patients.

Menezes CN, Crowther NJ, Duarte R, Van Amsterdam D, Evans D, Dickens C, Dix-Peek T, Rassool M, Prinsloo A, Raal F, Sanne I.

HIV Med. 2014 Jan;15(1):3-12. doi: 10.1111/hiv.12074. Epub 2013 Aug 28.

6.

Impact of nutritional supplementation on immune response, body mass index and bioelectrical impedance in HIV-positive patients starting antiretroviral therapy.

Evans D, McNamara L, Maskew M, Selibas K, van Amsterdam D, Baines N, Webster T, Sanne I.

Nutr J. 2013 Aug 6;12:111. doi: 10.1186/1475-2891-12-111.

7.

The early effects of stavudine compared with tenofovir on adipocyte gene expression, mitochondrial DNA copy number and metabolic parameters in South African HIV-infected patients: a randomized trial.

Menezes CN, Duarte R, Dickens C, Dix-Peek T, Van Amsterdam D, John MA, Ive P, Maskew M, Macphail P, Fox MP, Raal F, Sanne I, Crowther NJ.

HIV Med. 2013 Apr;14(4):217-25. doi: 10.1111/j.1468-1293.2012.01054.x. Epub 2012 Oct 4.

8.

Randomized trial of time-limited interruptions of protease inhibitor-based antiretroviral therapy (ART) vs. continuous therapy for HIV-1 infection.

Firnhaber C, Azzoni L, Foulkes AS, Gross R, Yin X, Van Amsterdam D, Schulze D, Glencross DK, Stevens W, Hunt G, Morris L, Fox L, Sanne I, Montaner LJ.

PLoS One. 2011;6(6):e21450. doi: 10.1371/journal.pone.0021450. Epub 2011 Jun 28.

9.

Matrix metalloproteases in bronchoalveolar lavage fluid of patients with type III Pseudomonas aeruginosa pneumonia.

El-Solh AA, Amsterdam D, Alhajhusain A, Akinnusi ME, Saliba RG, Lynch SV, Wiener-Kronish JP.

J Infect. 2009 Jul;59(1):49-55. doi: 10.1016/j.jinf.2009.05.004. Epub 2009 May 23.

10.

Preclinical and clinical performance of the Efoora test, a rapid test for detection of human immunodeficiency virus-specific antibodies.

Arens MQ, Mundy LM, Amsterdam D, Barrett JT, Bigg D, Bruckner D, Hanna B, Prince H, Purington T, Hanna T, Hewitt R, Kalinka C, Koppes T, Maxwell S, Moe A, Doymaz M, Poulter M, Saber-Tehrani M, Simard L, Wilkins-Carmody D, Vidaver J, Berger C, Davis AH, Alzona MT.

J Clin Microbiol. 2005 May;43(5):2399-406.

11.

Adhesion molecules in patients with coronary artery disease and moderate-to-severe obstructive sleep apnea.

El-Solh AA, Mador MJ, Sikka P, Dhillon RS, Amsterdam D, Grant BJ.

Chest. 2002 May;121(5):1541-7.

PMID:
12006441
13.

Prevention of disseminated Mycobacterium avium complex infection with reduced dose clarithromycin in patients with advanced HIV disease.

Hewitt RG, Papandonatos GD, Shelton MJ, Hsiao CB, Harmon BJ, Kaczmarek SR, Amsterdam D.

AIDS. 1999 Jul 30;13(11):1367-72.

PMID:
10449290
14.

Mycobacterium bovis BCG causing vertebral osteomyelitis (Pott's disease) following intravesical BCG therapy.

Aljada IS, Crane JK, Corriere N, Wagle DG, Amsterdam D.

J Clin Microbiol. 1999 Jun;37(6):2106-8.

15.

Monitoring and diagnosis of cytomegalovirus infection in renal transplantation.

Murray BM, Amsterdam D, Gray V, Myers J, Gerbasi J, Venuto R.

J Am Soc Nephrol. 1997 Sep;8(9):1448-57.

16.

The laboratory diagnosis of cytomegalovirus infections.

Myers JB, Amsterdam D.

Immunol Invest. 1997 Apr;26(3):383-94.

PMID:
9129990
17.

Polymerase chain reaction assays for the detection of cytomegalovirus in organ and bone marrow transplant recipients.

Evans MJ, Edwards-Spring Y, Myers J, Wendt A, Povinelli D, Amsterdam D, Rittenhouse-Diakun K, Armstrong D, Murray BM, Greenberg SJ, Riepenhoff-Talty M.

Immunol Invest. 1997 Jan-Feb;26(1-2):209-29.

PMID:
9037625
18.
19.

Mycobacterium malmoense bacteremia in two AIDS patients.

Fakih M, Chapalamadugu S, Ricart A, Corriere N, Amsterdam D.

J Clin Microbiol. 1996 Mar;34(3):731-3.

20.

In-vitro activity of trospectromycin against gram-positive cocci.

Beam TR Jr, Gorzynski EA, Rotstein C, Amsterdam D.

J Antimicrob Chemother. 1995 Nov;36(5):874-8. No abstract available.

PMID:
8626271
21.

Mechanical dysfunction in the border zone of an ovine model of left ventricular aneurysm.

Moulton MJ, Downing SW, Creswell LL, Fishman DS, Amsterdam DM, Szabó BA, Cox JL, Pasque MK.

Ann Thorac Surg. 1995 Oct;60(4):986-97; discussion 998.

PMID:
7575006
22.

Susceptibility of bacteraemic isolates of gram-positive cocci to daptomycin and other antimicrobial agents.

Amsterdam D, Gorzynski EA, Beam TR, Rotstein C.

J Antimicrob Chemother. 1994 May;33(5):1060-4. No abstract available.

PMID:
8089056
23.

The cytomegalovirus-antigenemia assay in the diagnosis of posttransplant cytomegalovirus infection.

Murray BM, Brentjens J, Amsterdam D, Myers J, Gray V, Pawlowski I, Schewegler K, Singh JP, Venuto RC.

J Am Soc Nephrol. 1994 Feb;4(8):1615-22.

24.

In vitro activity of sparfloxacin, ciprofloxacin, ofloxacin, and other antibiotics against bloodstream isolates of gram-positive cocci.

Rotstein C, Amsterdam D, Beam TR Jr, Mandell LA, Gorzynski EA.

Diagn Microbiol Infect Dis. 1993 Jul;17(1):85-91.

PMID:
8395375
25.

In vitro activities of ramoplanin, selected glycopeptides, fluoroquinolones, and other antibiotics against clinical bloodstream isolates of gram-positive cocci.

Lawrence T, Rotstein C, Beam TR Jr, Gorzynski EA, Amsterdam D.

Antimicrob Agents Chemother. 1993 Apr;37(4):896-900.

26.
27.

Detection of bacteriuria and pyuria by URISCREEN a rapid enzymatic screening test.

Pezzlo MT, Amsterdam D, Anhalt JP, Lawrence T, Stratton NJ, Vetter EA, Peterson EM, de la Maza LM.

J Clin Microbiol. 1992 Mar;30(3):680-4.

28.

Microbiological aspects of peritonitis associated with continuous ambulatory peritoneal dialysis.

von Graevenitz A, Amsterdam D.

Clin Microbiol Rev. 1992 Jan;5(1):36-48. Review.

29.

The in-vitro activity of temafloxacin, against gram-positive bacteria.

Mandell LA, Lawrence T, Rotstein C, Gorzynski EA, Beam TR, Amsterdam D.

J Antimicrob Chemother. 1991 Dec;28 Suppl C:15-24.

PMID:
1664826
30.

Evaluation of the modified Visuwell Strep-A enzyme immunoassay for detection of group-A Streptococcus from throat swabs.

Drulak M, Bartholomew W, LaScolea L, Amsterdam D, Gunnersen N, Yong J, Fijalkowski C, Winston S.

Diagn Microbiol Infect Dis. 1991 Jul-Aug;14(4):281-5.

PMID:
1889180
31.

Evaluation of a visual, rapid, membrane enzyme immunoassay for the detection of herpes simplex virus antigen.

Zimmerman SJ, Moses E, Sofat N, Bartholomew WR, Amsterdam D.

J Clin Microbiol. 1991 Apr;29(4):842-5.

32.

Case report and seeded blood culture study of Brucella bacteremia.

Zimmerman SJ, Gillikin S, Sofat N, Bartholomew WR, Amsterdam D.

J Clin Microbiol. 1990 Sep;28(9):2139-41.

33.
34.

Comparative in vitro susceptibilities of 504 bacteremic isolates to ticarcillin plus clavulanic acid and other antimicrobial agents.

Rotstein C, Amsterdam D, Beam T Jr, Gorzynski E.

Diagn Microbiol Infect Dis. 1989 Mar-Apr;12(2):157-63.

PMID:
2752713
35.

Neisseria meningitidis and Moraxella osloensis: dual infection in blood and peritoneal fluid.

Tiosejo LL, Hocko M, Bartholomew WR, Amsterdam D.

Diagn Microbiol Infect Dis. 1988 Dec;11(4):209-13.

PMID:
3149224
36.

Long-term evaluation of the hepatitis B vaccine (Heptavax-B) in hemodialysis patients.

Pasko MT, Bartholomew WR, Beam TR Jr, Amsterdam D, Cunningham EE.

Am J Kidney Dis. 1988 Apr;11(4):326-31.

PMID:
2965511
37.

Instrumentation for antimicrobic susceptibility testing: yesterday, today, and tomorrow.

Amsterdam D.

Diagn Microbiol Infect Dis. 1988 Mar;9(3):167-78. No abstract available.

39.

Evaluation of HLA-DR typing by ethidium bromide fluorescence.

Shanahan TC, Grybel MB, Cohen E, Fritz DD, Amsterdam D.

Ann Clin Lab Sci. 1987 Jul-Aug;17(4):236-40.

PMID:
3619399
40.

Septicemia due to DF-2. Cause of a false-positive cryptococcal latex agglutination result.

Westerink MA, Amsterdam D, Petell RJ, Stram MN, Apicella MA.

Am J Med. 1987 Jul;83(1):155-8.

PMID:
3605167
41.

The Attributional Style Questionnaire is not transparent.

Schulman P, Seligman ME, Amsterdam D.

Behav Res Ther. 1987;25(5):391-5. No abstract available.

PMID:
3689296
42.

Staphylococcal peritonitis in patients on continuous peritoneal dialysis.

West TE, Walshe JJ, Krol CP, Amsterdam D.

J Clin Microbiol. 1986 May;23(5):809-12.

43.

Pathophysiology of primary meningococcal pericarditis associated with Neisseria meningitidis group C. A case report and review of the literature.

Hardy DJ, Bartholomew WR, Amsterdam D.

Diagn Microbiol Infect Dis. 1986 Mar;4(3):259-65. Review.

PMID:
3082584
44.
45.

Application of bioluminescent urine screens in a tertiary care facility.

Males BM, Bartholomew WR, Amsterdam D.

Diagn Microbiol Infect Dis. 1986 Jan;4(1):1-10.

PMID:
3943288
46.

Leukocyte esterase-nitrite and bioluminescence assays as urine screens.

Males BM, Bartholomew WR, Amsterdam D.

J Clin Microbiol. 1985 Oct;22(4):531-4.

47.

Staphylococcus simulans septicemia in a patient with chronic osteomyelitis and pyarthrosis.

Males BM, Bartholomew WR, Amsterdam D.

J Clin Microbiol. 1985 Feb;21(2):255-7.

48.

Modified enzyme immunoassay for detecting Neisseria gonorrhoeae antigens.

Papasian CJ, Bartholomew WR, Amsterdam D.

J Clin Microbiol. 1984 Oct;20(4):641-3.

49.
50.

Endocarditis due to Actinobacillus actinomycetemcomitans serotype c and patient immune response.

Pierce CS, Bartholomew WR, Amsterdam D, Neter E, Zambon JJ.

J Infect Dis. 1984 Mar;149(3):479. No abstract available.

PMID:
6715906

Supplemental Content

Loading ...
Support Center